Literature DB >> 9278940

[Relationship between cholinergic symptoms caused by distigmine and the activities of serum AChE and BChE].

M Koga1, H Miyata, N Tsuno, K Nakayama, S Ushijima, Y Tanaka, Y Hiraga, N Kobayashi.   

Abstract

Distigmine is widely used for the treatment of dysuria, which is caused by various types of psychotropic medications. Distigmine, however, is also known to induce adverse cholinergic effects, such as diarrhea and salivation, with a decreased level of serum cholinesterase. We evaluated the possibility of using serum acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) as specific clinical markers for the adverse cholinergic effects of distigmine. Of the twelve patients treated with distigmine for dysuria caused by psychotropic drugs six patients presented both adverse cholinergic effects and decreased levels of serum AChE and BChE. The other six presented neither of these changes. This study suggests that the values of serum AChE and BChE may be useful markers for the manifestation of adverse cholinergic effects caused by distigmine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278940

Source DB:  PubMed          Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi        ISSN: 1340-2544


  1 in total

1.  Ubretid (distigmine bromide) taken to treat urinary retention prolongs the effect of suxamethonium.

Authors:  Shiroh Isono; Kei Iizuka; Goro Fukami; Norihiro Shinozuka; Masaomi Iyo; Takashi Nishino
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.